UT-231B

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameUT-231B
Drug Alias NameUT-231UT-231B
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionα-Galactosidase inhibitors
Targetsα-Galactosidase
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Oxford
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUnited Therapeutics Corp
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A